Adial Pharmaceuticals, Inc. Files PCT Patent Application to Protect Core Assets and Extend IP Exclusivity on Core Technology to At Least 2045 – MarketScreener

Adial Pharmaceuticals, Inc. Files PCT Patent Application to Protect Core Assets and Extend IP Exclusivity on Core Technology to At Least 2045  MarketScreener